There are 2789 resources available
Recent advances in ALK+ NSCLC
Presenter: Ben Solomon
Session: Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion
Resources:
Webcast
Treatment selection and sequencing: decision making in 2021
Presenter: Todd Bauer
Session: Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion
Resources:
Webcast
The importance of managing CNS disease
Presenter: Nicolas Girard
Session: Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion
Resources:
Webcast
Optimising patient outcomes: treatment management options
Presenter: Ibiayi Dagogo-Jack
Session: Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion
Resources:
Webcast
Q+A session
Presenter: Ibiayi Dagogo-Jack
Session: Pfizer Oncology - Expert Perspectives in ALK+NSCLC: a round table discussion
Resources:
Webcast
Moving forward in the treatment of endocrine-sensitive HR+/HER2– aBC
Presenter: Debra Patt
Session: Pfizer Oncology - Confidence and clarity in advanced breast cancer: Insights from the real world
Resources:
Webcast
Increasing clarity in diagnosing and treating germline BRCA-mutated aBC
Presenter: Fernando Petracci
Session: Pfizer Oncology - Confidence and clarity in advanced breast cancer: Insights from the real world
Resources:
Webcast
Welcome & introduction
Presenter: Véronique Diéras
Session: Pfizer Oncology - Confidence and clarity in advanced breast cancer: Insights from the real world
Resources:
Webcast
Building confidence in the treatment of challenging populations in endocrine-resistant HR+/HER2– aBC
Presenter: Rebecca Dent
Session: Pfizer Oncology - Confidence and clarity in advanced breast cancer: Insights from the real world
Resources:
Webcast
Q&A and discussion
Presenter: Debra Patt
Session: Pfizer Oncology - Confidence and clarity in advanced breast cancer: Insights from the real world
Resources:
Webcast